Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
WEHI-345 reduces mRNA levels of NF-kB targets such as TNF
Jpn J Antibiot
Capravirine
22)/b12-8-
Idebenone Catalog No.:M9526-2 WEHI-345 reduces mRNA levels ofIdebenone, also known as CV 2619, ss a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. As of December 2013 the drug is not approved for these indications in North America or Europe, but it is approved for the treatment of Leber's hereditary optic neuropathy (LHON) in Europe. Product information CAS Number: 58186 27 9 Molecular Weight: 338. 44 Formula: C19H30O5
US$ 24.95
US$ 19.95
US$ 14.95
US$ 21.95